Donovan Flumens

Antwerpen, VLG 2610, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Advances in ex vivo mRNA-based gene transfer for cell-based cancer immunotherapy.

Advances in ex vivo mRNA-based gene transfer for cell-based cancer immunotherapy.

Journal: Molecular therapy. Nucleic acids

Published: July 12, 2026

The search for safe and effective CAR-T targets in AML.

The search for safe and effective CAR-T targets in AML.

Journal: Blood cancer journal

Published: March 01, 2026

RNA-based co-transfer of human CD8αβ with WT1-specific TCRαβ redirects tumor recognition by CD4 and γδ T-cells towards MHC class I-restricted WT1 epitopes and boosts CD8 T-cell responses with or without CD3 mRNA.

RNA-based co-transfer of human CD8αβ with WT1-specific TCRαβ redirects tumor recognition by CD4 and γδ T-cells towards MHC class I-restricted WT1 epitopes and boosts CD8 T-cell responses with or without CD3 mRNA.

Journal: Experimental hematology & oncology

Published: December 18, 2025

Strategies to eliminate native T cell receptors for adoptive T cell therapies.

Strategies to eliminate native T cell receptors for adoptive T cell therapies.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: October 06, 2025

Training of epitope-TCR prediction models with healthy donor-derived cancer-specific T cells.

Training of epitope-TCR prediction models with healthy donor-derived cancer-specific T cells.

Journal: Methods in cell biology

Published: March 28, 2024

Analysis of Wilms' tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed.

Analysis of Wilms' tumor protein 1 specific TCR repertoire in AML patients uncovers higher diversity in patients in remission than in relapsed.

Journal: Annals of hematology

Published: March 14, 2024

One-step CRISPR-Cas9-mediated knockout of native TCRαβ genes in human T cells using RNA electroporation.

One-step CRISPR-Cas9-mediated knockout of native TCRαβ genes in human T cells using RNA electroporation.

Journal: STAR protocols

Published: November 28, 2022

In vitro expansion of Wilms' tumor protein 1 epitope-specific primary T cells from healthy human peripheral blood mononuclear cells.

In vitro expansion of Wilms' tumor protein 1 epitope-specific primary T cells from healthy human peripheral blood mononuclear cells.

Journal: STAR protocols

Published: October 13, 2022

Two for one: targeting BCMA and CD19 in B-cell malignancies with off-the-shelf dual-CAR NK-92 cells.

Two for one: targeting BCMA and CD19 in B-cell malignancies with off-the-shelf dual-CAR NK-92 cells.

Journal: Journal of translational medicine

Published: November 25, 2021

Anti-Tumor Potency of Short-Term Interleukin-15 Dendritic Cells Is Potentiated by In Situ Silencing of Programmed-Death Ligands.

Anti-Tumor Potency of Short-Term Interleukin-15 Dendritic Cells Is Potentiated by In Situ Silencing of Programmed-Death Ligands.

Journal: Frontiers in immunology

Published: June 30, 2021

The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy.

The Ins and Outs of Messenger RNA Electroporation for Physical Gene Delivery in Immune Cell-Based Therapy.

Journal: Pharmaceutics

Published: January 19, 2021

Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma.

Safety and clinical efficacy of BCMA CAR-T-cell therapy in multiple myeloma.

Journal: Journal of hematology & oncology

Published: October 11, 2020

Showing 1-12 of 13

Last Updated: 09/26/2026